Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free KROS Stock Alerts

Keros Therapeutics (KROS) SEC Filings & 10K Form

Keros Therapeutics logo
$17.03 +0.11 (+0.65%)
(As of 12/20/2024 05:31 PM ET)
Compare

Recent Keros Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
12/12/2024
5:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
6:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:02 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:18 PM		CHYUNG YUNG H. (Reporting)
Keros Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
3:22 PM		Keros Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:00 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:06 PM		GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:01 PM		Keros Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:12 PM		Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:02 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:15 PM		Keros Therapeutics (Filer)
Form 424B5
06/17/2024
4:17 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
5:07 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:10 PM		BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2024
3:11 PM		BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
3:15 PM		Farzan Nima (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		GRAY MARY ANN (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Keros Therapeutics (Issuer)
Knowles Julius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:03 AM		Keros Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
7:00 AM		Keros Therapeutics (Filer)
Form S-3ASR
03/14/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:02 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
3:02 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:37 PM		Cooper Simon Peter (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:38 PM		Keros Therapeutics (Issuer)
Rovaldi Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:40 PM		Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:41 PM		Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:38 PM		ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Keros Therapeutics (Subject)
Form SC 13G/A
Buy this coin BEFORE Inauguration Day … (Ad)

Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.

This could be his favorite coin.
02/09/2024
8:16 AM		FMR LLC (Filed by)
Keros Therapeutics (Subject)
Form SC 13G/A
01/26/2024
4:26 PM		BlackRock Inc. (Filed by)
Keros Therapeutics (Subject)
Form SC 13G/A
01/09/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:43 PM		Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM		Keros Therapeutics (Filer)
Form 424B5
01/04/2024
3:04 PM		Keros Therapeutics (Subject)
Regnante Keith (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:04 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
7:04 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KROS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Behind the Markets | Sponsored